Medical Research
(H900)
IRS Verified
DX Registered
990 on File
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL
Financial strength (30%)
70/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$91.6M
Total Revenue
$99.2M
Total Expenses
$81.8M
Net Assets
768
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
67.7%
Fundraising Efficiency
12588.1%
Operating Reserve
9.90x
Liability-to-Asset
51.8%
Revenue Diversification
91.1%
Executive Compensation
$3.1M
Compared with Peers
FY 2023
Compared with 132 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
67.7% | 82.7% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
30.9% | 13.5% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
1.4% | 0.0% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
12588.1% | 639.6% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
9.9 mo | 12.6 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
51.8% | 29.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
91.1% | 91.9% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
7.6% | 7.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
7.9% | 10.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-8.3% | -2.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $91.6M | $99.2M | $81.8M | 67.7% | 768 |
| 2022 | $85.2M | $92.0M | $87.1M | 68.4% | 768 |
| 2021 | $163.3M | $90.5M | N/A | — | 780 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.